Melexis N.V.
MLXSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.73 | 0.27 | 0.68 | -0.61 |
| FCF Yield | 1.38% | 0.47% | 0.46% | 1.21% |
| EV / EBITDA | 56.32 | 39.03 | 62.45 | 78.33 |
| Quality | ||||
| ROIC | 3.62% | 3.66% | 3.08% | 3.24% |
| Gross Margin | 38.75% | 39.04% | 38.17% | 39.29% |
| Cash Conversion Ratio | 1.62 | 0.48 | 0.67 | 2.58 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.85% | -2.01% | 0.32% | 3.71% |
| Free Cash Flow Growth | 311.98% | -5.58% | -68.63% | -3.08% |
| Safety | ||||
| Net Debt / EBITDA | 4.92 | 4.53 | 4.63 | 4.81 |
| Interest Coverage | 12.56 | 0.00 | 62.73 | 6.28 |
| Efficiency | ||||
| Inventory Turnover | 0.44 | 0.45 | 0.43 | 0.46 |
| Cash Conversion Cycle | 223.79 | 243.24 | 211.37 | 196.52 |